SG131029A1 - New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it - Google Patents
New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing itInfo
- Publication number
- SG131029A1 SG131029A1 SG200605972-9A SG2006059729A SG131029A1 SG 131029 A1 SG131029 A1 SG 131029A1 SG 2006059729 A SG2006059729 A SG 2006059729A SG 131029 A1 SG131029 A1 SG 131029A1
- Authority
- SG
- Singapore
- Prior art keywords
- agomelatine
- pharmaceutical compositions
- compositions containing
- new association
- thymoregulatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/08—Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0509208A FR2890563B1 (fr) | 2005-09-09 | 2005-09-09 | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
SG131029A1 true SG131029A1 (en) | 2007-04-26 |
Family
ID=36190792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200605972-9A SG131029A1 (en) | 2005-09-09 | 2006-08-31 | New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it |
Country Status (38)
Country | Link |
---|---|
US (1) | US7902180B2 (zh) |
EP (2) | EP1762238B1 (zh) |
JP (1) | JP2007077149A (zh) |
KR (2) | KR20070029607A (zh) |
CN (1) | CN1927194A (zh) |
AP (1) | AP3045A (zh) |
AR (1) | AR055418A1 (zh) |
AT (1) | ATE519482T1 (zh) |
AU (1) | AU2006209371B2 (zh) |
BR (1) | BRPI0603767A (zh) |
CA (1) | CA2558764C (zh) |
CY (1) | CY1112223T1 (zh) |
DK (1) | DK1762238T3 (zh) |
EA (1) | EA014381B1 (zh) |
ES (1) | ES2371482T3 (zh) |
FR (1) | FR2890563B1 (zh) |
GE (1) | GEP20094741B (zh) |
GT (1) | GT200600410A (zh) |
HR (1) | HRP20110749T1 (zh) |
JO (1) | JO2746B1 (zh) |
MA (1) | MA28504B1 (zh) |
ME (1) | ME01964B (zh) |
MX (1) | MXPA06010234A (zh) |
MY (1) | MY162318A (zh) |
NO (1) | NO338079B1 (zh) |
NZ (1) | NZ549727A (zh) |
PE (1) | PE20070613A1 (zh) |
PL (1) | PL1762238T3 (zh) |
PT (1) | PT1762238E (zh) |
RS (1) | RS52003B (zh) |
SA (1) | SA110320045B1 (zh) |
SG (1) | SG131029A1 (zh) |
SI (1) | SI1762238T1 (zh) |
TW (1) | TWI369980B (zh) |
UA (1) | UA83541C2 (zh) |
UY (1) | UY29776A1 (zh) |
WO (1) | WO2007028903A1 (zh) |
ZA (1) | ZA200607532B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
EP1185259A1 (en) * | 1999-04-29 | 2002-03-13 | MERCK PATENT GmbH | Glycine cleavage system inhibitors as potential antipsychotics |
PL357472A1 (en) * | 1999-12-01 | 2004-07-26 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
AR047553A1 (es) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina |
FR2884714B1 (fr) * | 2005-04-20 | 2011-05-06 | Servier Lab | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires |
-
2005
- 2005-09-09 FR FR0509208A patent/FR2890563B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-22 MA MA29280A patent/MA28504B1/fr unknown
- 2006-08-29 CN CNA2006101265895A patent/CN1927194A/zh active Pending
- 2006-08-31 UY UY29776A patent/UY29776A1/es not_active Application Discontinuation
- 2006-08-31 SG SG200605972-9A patent/SG131029A1/en unknown
- 2006-09-04 PE PE2006001069A patent/PE20070613A1/es not_active Application Discontinuation
- 2006-09-06 SA SA110320045A patent/SA110320045B1/ar unknown
- 2006-09-07 US US11/516,992 patent/US7902180B2/en not_active Expired - Fee Related
- 2006-09-07 GE GEAP20069610A patent/GEP20094741B/en unknown
- 2006-09-07 JO JO2006303A patent/JO2746B1/en active
- 2006-09-07 MY MYPI20064103A patent/MY162318A/en unknown
- 2006-09-07 NZ NZ549727A patent/NZ549727A/en not_active IP Right Cessation
- 2006-09-08 AP AP2008004380A patent/AP3045A/xx active
- 2006-09-08 BR BRPI0603767-4A patent/BRPI0603767A/pt not_active Application Discontinuation
- 2006-09-08 GT GT200600410A patent/GT200600410A/es unknown
- 2006-09-08 AR ARP060103909A patent/AR055418A1/es not_active Application Discontinuation
- 2006-09-08 DK DK06291423.9T patent/DK1762238T3/da active
- 2006-09-08 RS RS20110407A patent/RS52003B/en unknown
- 2006-09-08 EA EA200601450A patent/EA014381B1/ru not_active IP Right Cessation
- 2006-09-08 ME MEP-2011-407A patent/ME01964B/me unknown
- 2006-09-08 EP EP06291423A patent/EP1762238B1/fr active Active
- 2006-09-08 UA UAA200609685A patent/UA83541C2/uk unknown
- 2006-09-08 TW TW095133157A patent/TWI369980B/zh not_active IP Right Cessation
- 2006-09-08 AT AT06291423T patent/ATE519482T1/de active
- 2006-09-08 AU AU2006209371A patent/AU2006209371B2/en not_active Ceased
- 2006-09-08 ZA ZA2006/07532A patent/ZA200607532B/en unknown
- 2006-09-08 NO NO20064049A patent/NO338079B1/no not_active IP Right Cessation
- 2006-09-08 EP EP10011609A patent/EP2301527A1/fr not_active Withdrawn
- 2006-09-08 PL PL06291423T patent/PL1762238T3/pl unknown
- 2006-09-08 ES ES06291423T patent/ES2371482T3/es active Active
- 2006-09-08 MX MXPA06010234A patent/MXPA06010234A/es active IP Right Grant
- 2006-09-08 SI SI200631105T patent/SI1762238T1/sl unknown
- 2006-09-08 WO PCT/FR2006/002066 patent/WO2007028903A1/fr active Application Filing
- 2006-09-08 PT PT06291423T patent/PT1762238E/pt unknown
- 2006-09-08 CA CA2558764A patent/CA2558764C/fr not_active Expired - Fee Related
- 2006-09-11 KR KR1020060087623A patent/KR20070029607A/ko not_active Application Discontinuation
- 2006-09-11 JP JP2006245011A patent/JP2007077149A/ja active Pending
-
2009
- 2009-05-04 KR KR1020090038945A patent/KR20090056949A/ko not_active Application Discontinuation
-
2011
- 2011-09-08 CY CY20111100868T patent/CY1112223T1/el unknown
- 2011-10-14 HR HR20110749T patent/HRP20110749T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196462A (en) | (s) - n - (3 - chloro - 4 - cyanophenyl) - 3 - (4 - cyanophenoxy) - 2 - hydroxy - 2 - methylpropanamide, composition and use | |
PL1894567T3 (pl) | Środki farmaceutyczne do podawania skojarzonego oraz ich zastosowanie | |
IL231576A (en) | Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines | |
IL197923A (en) | Synthetic peptides, pharmaceutical preparations containing them and their uses | |
IL181964A0 (en) | Medicaments comprising carbonyl compounds, and the use thereof | |
EP1731524A4 (en) | PHENOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE, AND ITS MEDICINAL USE | |
IL193678A (en) | Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity | |
TW200716119A (en) | A solid pharmaceutical dosage formulation | |
IL189781A0 (en) | Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same | |
HK1244819A1 (zh) | Foxm1肽和包含foxm1肽的藥劑 | |
IL188732A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
IL195935A0 (en) | 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same | |
SI1912644T1 (sl) | Derivati N-(arilalkil)-1H-pirolopiridin-2-karboksamidov, njihova priprava in njihova terapevtska uporaba | |
EP1731609A4 (en) | INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF | |
ZA200801987B (en) | N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals | |
TW200738635A (en) | New salt | |
EP1902710A4 (en) | PHARMACEUTICAL COMPOSITION AND BEVERAGE COMPOSITION COMPRISING L-ARGININE | |
MY139425A (en) | Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol | |
SG131030A1 (en) | New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it | |
IL191992A0 (en) | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications | |
JO2666B1 (en) | Use of agomelatine for medications to treat bilateral mental disorders | |
MY145139A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of smith-magenis syndrome | |
IL190830A0 (en) | Stable pharmaceutical formulaions containing escitalopram and bupropion | |
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
SG131029A1 (en) | New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it |